Written by Dr. Datis Kharrazian Science has reliably proven that environmental pollutants, chemicals, and toxins can trigger autoimmunity. These chemicals include mercury, lead, benzene, solvents, and other compounds found in our everyday environment — carpets, mattresses, plastic utensils, plastic water bottles, fire retardants found in furniture and children’s pajamas, etc. Many people mistakenly believe the […]
09.28.2015 NIH will help finance second study by Larry Husten CardioBrief The National Institutes of Health is giving money to support the planning of a second trial to test the potential role of chelation therapy in treating patients with myocardial infarction. The first Trial to Assess Chelation Therapy (TACT) was extremely controversial. It was funded […]
JAMES HAMBLINSEP 17 2014 Story Source A controversial treatment designed to remove environmental metals from the body might be effective in treating heart disease. Will one renegade doctor persuade the rest of the medical establishment to consider it? “For me, this is the big one.” Gervasio Lamas, the chief of Columbia University’s cardiology division at Mount […]
MedPageToday.com Published: Jul 7, 2014 By Todd Neale, Senior Staff Writer, MedPage Today A new TACT analysis showed that chelation therapy did not enhance quality of life in patients recovering from a heart attack. Also, very late stent thrombosis does not appear to be a major issue with newer drug-eluting stents. Chelation Fails to Improve […]
Published: Nov 25, 2013 By Todd Neale, Senior Staff Writer, MedPage Today Chelation Has Benefits in Patients With Diabetes Chelation reduced major cardiovascular events in patients with diabetes, but not in those without diabetes, a subgroup analysis of the TACT trial showed. The overall trial results, reported at the American Heart Association meeting last year, showed a […]
Wednesday, 27 November 2013 01:03 By Erik Goldman Amid the controversy over the new statin therapy guidelines, it was easy to overlook an equally important report from the American Heart Association’s 2013 annual meeting: the finding that intravenous EDTA chelation therapy substantially reduces cardiovascular events in people with diabetes. The report, from the NIH-funded Trial to Assess […]
Vitamins alone won’t improve outcomes for patients who’ve had a heart attack, but they do appear to have additive benefits when given in conjunction with chelation therapy.
Published: Mar 26, 2013 By Chris Kaiser , Cardiology Editor, MedPage Today Action Points Note that this troubled randomized trial showed a modest benefit to chelation therapy in secondary prevention after myocardial infarction. Be aware that greater dropout in the placebo group suggests unblinding of the intervention. Note that many sites participating in the trial […]